Unlike older weight loss medications, tirzepatide does not cross into intestinal tissue to cause inflammation, but its effects on gastric motility can shift how food moves through the stomach and small intestine
She explains that flexible tapering strategies are key to successful antidepressant discontinuation in primary care GLP-1 receptor agonists: Optimising nutritional outcomes in primary care GLP-1 receptor agonists: Optimising nutritional outcomes in primary care Dietitian Sarah MacAvoy explains that while new weight-loss medications show exciting potential, they also put patients at risk of nutritional deficiencies, and dietitian support is essential Kia ora and welcome to Pharmacy Today Kaitiaki Rongo O Te W Not a subscriber
Wegovy has been licensed as a weight-loss treatment, but other forms of semaglutide are currently only licensed for treating diabetes
If you are ready to take the first step toward a healthier version of yourself, we invite you to begin your journey today
J1341, J1342, J1343 Triglyceride-Glo Assay Detects triglyceride levels by measuring glycerol that is released from an enzymatic reaction with a lipase